---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-009945"
form_type: "8-K"
ticker: null
cik: "0001300734"
company_name: "SHINECO, INC."
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T13:25:59.966358+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Shineco closes acquisition of 75% of FuWang (HK) for ~US$8.9M cash plus stock

## Summary
- Shineco Life Science acquired 75% equity in FuWang (HK) from Yi Yang on May 12, 2025.
- Consideration: RMB 63.89M (~US$8.9M) cash, 3,400,000 Shineco shares, and 71.42% of Dream Partner Ltd.
- Shares issued under Regulation S; seller represented as non-U.S. person.
- Financial statements and pro forma financials to be filed by amendment within 71 days.

## SEC filing metadata
- accession: 0001641172-25-009945
- form_type: 8-K
- cik: 0001300734
- company_name: SHINECO, INC.
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1300734/000164117225009945/0001641172-25-009945-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1300734/000164117225009945/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-009945
- JSON: https://secwatch.observer/filing/0001641172-25-009945.json
- Plain text: https://secwatch.observer/filing/0001641172-25-009945.txt

## Key facts
- M&A Transactions
  SHINECO, INC. completed an acquisition involving Yi Yang for RMB 63.89 million (approximately US$8.9 million) in cash, 3,400,000 shares of common stock, and 71.42% equity interests in Dream Partner Limited (closed 2025-05-12).
  - Action: acquisition
  - Counterparty: Yi Yang
  - Consideration: RMB 63.89 million (approximately US$8.9 million) in cash, 3,400,000 shares of common stock, and 71.42% equity interests in Dream Partner Limited
  - Closing: 2025-05-12
  source text: in FuWang (HK) to Shineco Life Science; therefore, FuWang (HK) became a direct subsidiary of Shineco Life Science. In exchange, Shineco Life Science paid to the Seller RMB 63.89 million (approximately US$8.9 million) in cash, and the Company issued 3,400,000 shares of the Company’s common stock, par value $0.001 per share (the “Shares”) and transferred the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1300734/000164117225009945/0001641172-25-009945-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.